Literature DB >> 14675735

Insulin inhibits amyloid beta-induced cell death in cultured human brain pericytes.

Annemieke A M Rensink1, Irene Otte-Höller, Roelie de Boer, Remko R Bosch, Hans J ten Donkelaar, Robert M W de Waal, Marcel M Verbeek, Berry Kremer.   

Abstract

Amyloid-beta (Abeta) deposition in the cerebral arterial and capillary walls is one of the characteristics of Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis-Dutch type. In vitro, Abeta1-40, carrying the "Dutch" mutation (DAbeta1-40), induced reproducible degeneration of cultured human brain pericytes (HBP), by forming fibrils at the cell surface. Thus, this culture system provides an useful model to study the vascular pathology seen in Alzheimer's disease. In this study, we used this model to investigate the effects of insulin on Abeta-induced degeneration of HBP, as it has been mentioned previously that insulin is able to protect neurons against Abeta-induced cell-death. The toxic effect of DAbeta1-40 on HBP was inhibited by insulin in a dose-dependent matter. Insulin interacted with Abeta and inhibited fibril formation of Abeta in a cell-free assay, as well as at the cell surface of HBP. Our data indicate that the formation of a fibril network is essential for Abeta-induced cell death in HBP. Additionally, insulin may be involved in the regulation of Abeta fibrillization in AD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14675735     DOI: 10.1016/s0197-4580(03)00039-3

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  21 in total

1.  Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane.

Authors:  Maarten F M Engel; Lucie Khemtémourian; Cécile C Kleijer; Hans J D Meeldijk; Jet Jacobs; Arie J Verkleij; Ben de Kruijff; J Antoinette Killian; Jo W M Höppener
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-11       Impact factor: 11.205

2.  Prions disturb post-Golgi trafficking of membrane proteins.

Authors:  Keiji Uchiyama; Naomi Muramatsu; Masashi Yano; Takeshi Usui; Hironori Miyata; Suehiro Sakaguchi
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

Review 3.  Molecular and biochemical trajectories from diabetes to Alzheimer's disease: A critical appraisal.

Authors:  Rajat Sandhir; Smriti Gupta
Journal:  World J Diabetes       Date:  2015-09-25

Review 4.  Nutrient-driven O-GlcNAc in proteostasis and neurodegeneration.

Authors:  Ilhan Akan; Stephanie Olivier-Van Stichelen; Michelle R Bond; John A Hanover
Journal:  J Neurochem       Date:  2017-11-20       Impact factor: 5.372

Review 5.  Pericytes in Brain Injury and Repair After Ischemic Stroke.

Authors:  Wei Cai; Huan Liu; Jingyan Zhao; Lily Y Chen; Jun Chen; Zhengqi Lu; Xiaoming Hu
Journal:  Transl Stroke Res       Date:  2016-11-12       Impact factor: 6.829

6.  Insulin promotes survival of amyloid-beta oligomers neuroblastoma damaged cells via caspase 9 inhibition and Hsp70 upregulation.

Authors:  M Di Carlo; P Picone; R Carrotta; D Giacomazza; P L San Biagio
Journal:  J Biomed Biotechnol       Date:  2010-05-13

Review 7.  Brain insulin dysregulation: implication for neurological and neuropsychiatric disorders.

Authors:  Rasoul Ghasemi; Leila Dargahi; Ali Haeri; Maryam Moosavi; Zahurin Mohamed; Abolhassan Ahmadiani
Journal:  Mol Neurobiol       Date:  2013-01-20       Impact factor: 5.590

Review 8.  Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain.

Authors:  D Allan Butterfield; Fabio Di Domenico; Eugenio Barone
Journal:  Biochim Biophys Acta       Date:  2014-06-17

Review 9.  Insulin in the brain: sources, localization and functions.

Authors:  Rasoul Ghasemi; Ali Haeri; Leila Dargahi; Zahurin Mohamed; Abolhassan Ahmadiani
Journal:  Mol Neurobiol       Date:  2012-09-07       Impact factor: 5.590

10.  Lipoprotein receptor-related protein-1 mediates amyloid-beta-mediated cell death of cerebrovascular cells.

Authors:  Micha M M Wilhelmus; Irene Otte-Höller; Jos J J van Triel; Robert Veerhuis; Marion L C Maat-Schieman; Guojun Bu; Robert M W de Waal; Marcel M Verbeek
Journal:  Am J Pathol       Date:  2007-11-30       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.